In 143 patients with HFrEF, permanent AF and CRT-D (trial stopped early for futility), AV node ablation vs medical rate control did not reduce death or non-fatal heart failure events (47 vs 46 events; IRR 1.16, 95% CI 0.60–2.24); secondary outcomes also did not differ.
RCTn = 143
Sanders et al. Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial